

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fibrosis | D005355 | — | — | 1 | 1 | 4 | — | — | 6 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | 1 | 1 | 4 | — | — | 6 |
| Drug common name | Bamocaftor |
| INN | bamocaftor |
| Description | Bamocaftor is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target cystic fibrosis transmembrane conductance regulator. |
| Classification | Small molecule |
| Drug class | cystic fibrosis transmembrane regulator (CFTR) protein modulators |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C[C@@H]1CN(c2nc(-n3ccc(OCCC4(C(F)(F)F)CC4)n3)ccc2C(=O)NS(=O)(=O)c2ccccc2)C(C)(C)C1 |
| PDB | — |
| CAS-ID | 2204245-48-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4297849 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 8C7XEW3K7S (ChemIDplus, GSRS) |

